Sir Edward Penley Abraham(1913-1999), Biochemist
Sitter in 2 portraits
After completing his doctorate in Oxford, Abraham took up a position at the Sir William Dunn School of Pathology. He was a noted biochemist, his work on antibiotics producing great clinical advances. His principal work was concerned with the development of penicillin and later of cephalosporin, an antibiotic capable of destroying penicillin-resistant bacteria. These vital drugs are now used extensively in the treatment of various infections, including pneumonia, bronchitis, septicaemia and infected surgical wounds. Through the registration of patent on cephalosporin, he was able to generate a regular income, which he has devoted almost entirely to the establishment of a charitable trust for the support of biomedical research.